Industry Focus

Industry Focus

By The Motley FoolBusinessNewsBusiness News
Download on the App Store

Industry Focus episodes

  • Financials: Bank Earnings and Getting to Know Zelle

    In this episode, we look at the bank earnings (so far) and learn about person-to-person payment platform Zelle. In the latest edition of our Between Two Fools interview series, Fool.com contributor Matt Frankel, CFP sits down with Lou Anne Alexander, Group President of Payments for Early Warning, the company behind person-to-person payment platform Zelle. Later, Frankel and Industry Focus: Financials host Jason Moser discuss earnings from JPMorgan Chase (NYSE: JPM), and both tell listeners about the stocks on their radar this week.

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter
    27 min
  • Tech: A Profitable Unicorn?

    Soon-to-be-public Zoom is a Unicorn among Unicorns -- the company grew its top line over 100% last year and it managed to post a profit. We run through the company prospectus and see whether it is worth investing in ahead up its public debut:

    Stocks: ZM

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter
    26 min
  • Tech: A Profitable Unicorn?

    Soon-to-be-public Zoom is a Unicorn among Unicorns -- the company grew its top line over 100% last year and it managed to post a profit. We run through the company prospectus and see whether it is worth investing in ahead up its public debut:

    Stocks: ZM

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter
    26 min
  • Energy: DowDuPont Is Breaking Up -- What It Means For Investors.

    4 years ago, Dow and DuPont merged, creating one of the world’s largest industrial conglomerates. From the start, the plan was to break this newly formed company into 3 separate businesses, each more streamlined and nimble than the combined entity. In early April, the first stage of the breakup took place when New Dow began trading. Motley Fool Contributor Lou Whiteman and Industry Focus host Nick Sciple break down each of the newly formed companies and discuss how investors should be viewing them as they come to market.

    Stocks Mentioned: DWDP, DOW

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter
    25 min
  • Energy: DowDuPont Is Breaking Up -- What It Means For Investors.

    4 years ago, Dow and DuPont merged, creating one of the world’s largest industrial conglomerates. From the start, the plan was to break this newly formed company into 3 separate businesses, each more streamlined and nimble than the combined entity. In early April, the first stage of the breakup took place when New Dow began trading. Motley Fool Contributor Lou Whiteman and Industry Focus host Nick Sciple break down each of the newly formed companies and discuss how investors should be viewing them as they come to market.

    Stocks Mentioned: DWDP, DOW

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter
    25 min
  • Healthcare: 3 Genomics Stocks Revolutionizing Healthcare And Why Alnylam's New Deal Didn't Excite Investors

    Here's why a $1 billion deal with Regeneron failed to spark a rally in Alnylam shares. Also, will genetic discovery be our generation's biggest trend? If so, Illumina, bluebird bio, and Invitae could be top stocks to watch.

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter
    32 min
  • Healthcare: 3 Genomics Stocks Revolutionizing Healthcare And Why Alnylam's New Deal Didn't Excite Investors

    Here's why a $1 billion deal with Regeneron failed to spark a rally in Alnylam shares. Also, will genetic discovery be our generation's biggest trend? If so, Illumina, bluebird bio, and Invitae could be top stocks to watch.

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter
    32 min
  • CG: Is WWE A Predetermined Winner?

    WWE stock is up over 5X in the last three years, making it one of the better performing stocks on the market. With sports licensing fees surging, the company recently negotiated a new deal that should position the company to thrive over the next several years. Dan “Pretty Boy” Kline and Nick “Hundred Dollar Man” Sciple break down how the company makes money, recent criticism surrounding the company, and the company’s future on this week’s episode.

    Stay tuned till the end to hear our Mount Rushmore of the greatest wrestlers of all time, our favorite highlights from Sunday’s Wrestlemania, and more!

    Stocks Mentioned: WWE, FOX, FOXA, CMCSA

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter
    43 min
  • CG: Is WWE A Predetermined Winner?

    WWE stock is up over 5X in the last three years, making it one of the better performing stocks on the market. With sports licensing fees surging, the company recently negotiated a new deal that should position the company to thrive over the next several years. Dan “Pretty Boy” Kline and Nick “Hundred Dollar Man” Sciple break down how the company makes money, recent criticism surrounding the company, and the company’s future on this week’s episode.

    Stay tuned till the end to hear our Mount Rushmore of the greatest wrestlers of all time, our favorite highlights from Sunday’s Wrestlemania, and more!

    Stocks Mentioned: WWE, FOX, FOXA, CMCSA

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter
    43 min
  • Financials: An Insider’s Look at Financial Crimes and Why America Isn’t Living Up to Its Potential

    Here’s the latest from around the financial sector, and an interview with a Fool.com contributor with a unique perspective on financial crimes. In this episode of Industry Focus: Financials, host Jason Moser sits down with Fool.com contributor Matt Cochrane, who happens to have a unique day job related to the financial sector. Also, regular guest Matt Frankel, CFP discusses why JPMorgan Chase (NYSE: JPM) CEO Jamie Dimon thinks America’s economic growth isn’t nearly as robust as it could be, and answers a listener question about stock buybacks. Finally, as always, Moser and Frankel each reveal what stocks they’re watching right now.

    Check out more of our content here:

    • TMF's podcast portal
    • YouTube
    • Twitter
    • Join Our Motley Fool Podcast Facebook Group
    • LinkedIn
    • StockUp, The Motley Fool's weekly email newsletter
    34 min

About Industry Focus

From the publisher's feed

Healthcare, technology, energy, consumer goods, and more. Every day, Motley Fool analysts break down a specific industry and the stocks making headlines. Questions? Comments? Email us at…

More shows like Industry Focus

Motley Fool Hidden Gems Investing by The Motley Fool

Motley Fool Hidden Gems Investing

3,160 Listeners

Motley Fool Answers by The Motley Fool

Motley Fool Answers

807 Listeners

Rule Breaker Investing by The Motley Fool

Rule Breaker Investing

934 Listeners

MarketFoolery by The Motley Fool

MarketFoolery

1,604 Listeners